Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106154522 | 10615452 | 2 | F | 20160824 | 20141201 | 20160829 | PER | US-PFIZER INC-2014326181 | PFIZER | 74.00 | YR | F | Y | 78.00000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106154522 | 10615452 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, 2X/DAY | 20235 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 106154522 | 10615452 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | 1200 MG, DAILY (1 IN AM, 3 IN PM) | 20235 | 1200 | MG | CAPSULE, HARD | ||||||||
| 106154522 | 10615452 | 3 | SS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 2X/DAY | U | 20998 | 200 | MG | CAPSULE, HARD | BID | |||||
| 106154522 | 10615452 | 4 | SS | MEDROL | METHYLPREDNISOLONE | 1 | 4 MG, UNK, PER DOSE PACK INSTRUCTIONS | U | 11153 | 4 | MG | TABLET | |||||||
| 106154522 | 10615452 | 5 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 4.5 MG, DAILY | 0 | 4.5 | MG | TABLET | |||||||
| 106154522 | 10615452 | 6 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | CAPSULE | |||||||
| 106154522 | 10615452 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 112 ?G, 1X/DAY BEFORE BREAKFAST | 0 | 112 | UG | TABLET | QD | ||||||
| 106154522 | 10615452 | 8 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | CAPSULE | |||||||
| 106154522 | 10615452 | 9 | C | VITAMIN B-6 | PYRIDOXINE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 106154522 | 10615452 | 10 | C | ESTRACE | ESTRADIOL | 1 | Oral | 1 MG, DAILY | 0 | 1 | MG | TABLET | |||||||
| 106154522 | 10615452 | 11 | C | VALIUM | DIAZEPAM | 1 | Oral | 5 MG, 1X/DAY, EVERY EVENING | 0 | 5 | MG | TABLET | QD | ||||||
| 106154522 | 10615452 | 12 | C | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | [FLUTICASONE100 MCG]/[ SALMETEROL 50 MCG] TAKE 1 PUFF TWO TIMES A DAY | 0 | INHALATION POWDER | BID | |||||||||
| 106154522 | 10615452 | 13 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 180 MG, DAILY | 0 | 180 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 106154522 | 10615452 | 14 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 240 MG, DAILY | 0 | 240 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 106154522 | 10615452 | 15 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 2 DF, DAILY | 0 | 2 | DF | NASAL SPRAY | |||||||
| 106154522 | 10615452 | 16 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Oral | AS NEEDED (90 MCG/ACTUATION INHALER, INHALE 2 PUFFS BY MOUTH FOUR TIMES A DAY IF NEEDED) | 0 | INHALATION VAPOUR, LIQUID | |||||||||
| 106154522 | 10615452 | 17 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | TABLET | |||||||
| 106154522 | 10615452 | 18 | C | MOBIC | MELOXICAM | 1 | Oral | 15 MG, DAILY | 0 | 15 | MG | TABLET | |||||||
| 106154522 | 10615452 | 19 | C | PROVENTIL | ALBUTEROL | 1 | 2.5 MG, AS NEEDED (2.5 MG/ 3 ML, 3 ML BY NEBULIZATION ROUTE EVERY FOUR (4) HOURS) | 0 | 2.5 | MG | NEBULISER SOLUTION | ||||||||
| 106154522 | 10615452 | 20 | C | AMOXIL | AMOXICILLIN | 1 | 2000 MG, UNK (TAKE ALL 4 CAPS 1/2 HOUR BEFORE DENTAL WORK) | 0 | 2000 | MG | CAPSULE | ||||||||
| 106154522 | 10615452 | 21 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 1200 MG, 2X/DAY | 0 | 1200 | MG | MODIFIED-RELEASE TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106154522 | 10615452 | 1 | Neuropathy peripheral |
| 106154522 | 10615452 | 13 | Atrial fibrillation |
| 106154522 | 10615452 | 19 | Wheezing |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106154522 | 10615452 | Back pain | |
| 106154522 | 10615452 | Sensory disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106154522 | 10615452 | 1 | 20141117 | 0 | ||
| 106154522 | 10615452 | 3 | 20141117 | 0 |